Outset Medical, Inc. (OM) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 43.89M USD | Liabilities, Current |
| Cash and equivalents | 35.01M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 29.22M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 47.31M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $43.89M | $35.01M | (m) | $29.22M | $47.31M | (m) |
| 2026-03-31 | (m) | $37.61M | $30.56M | (m) | $25.32M | $49.65M | (m) |
| 2025-12-31 | (m) | $37.63M | $35.01M | (m) | $28.33M | $47.61M | (m) |
| 2025-09-30 | (m) | $37.45M | $36.44M | (m) | $32.96M | $49.29M | (m) |
| 2025-06-30 | $141.20M | $36.91M | $39.56M | $66.75M | $34.89M | $52.25M | 3.83× |
| 2025-03-31 | $123.33M | $34.22M | $75.93M | $10.52M | $36.89M | $55.77M | 3.60× |
| 2024-12-31 | $162.63M | $45.38M | $124.01M | $2.99M | $35.62M | $59.39M | 3.58× |
| 2024-09-30 | $70.20M | $42.43M | $33.29M | $2.66M | $34.26M | $61.44M | 1.65× |
| 2024-06-30 | $202.11M | $43.43M | $37.86M | $130.13M | $34.12M | $61.60M | 4.65× |
| 2024-03-31 | $226.54M | $50.67M | $32.18M | $157.89M | $36.48M | $55.84M | 4.47× |
| 2023-12-31 | $166.37M | $55.32M | $68.51M | $64.88M | $32.98M | $49.22M | 3.01× |
| 2023-09-30 | $164.44M | $53.02M | $36.30M | $92.65M | $35.49M | $48.26M | 3.10× |
| 2023-06-30 | $212.11M | $48.82M | $36.39M | $138.82M | $36.90M | $44.49M | 4.34× |
| 2023-03-31 | $158.12M | $44.27M | $36.39M | $87.42M | $34.31M | $47.73M | 3.57× |
| 2022-12-31 | (m) | $51.95M | $73.22M | (m) | $28.07M | $51.48M | (m) |
| 2022-09-30 | (m) | $49.64M | $63.88M | (m) | $22.51M | $55.26M | (m) |
| 2022-06-30 | (m) | $55.24M | $75.50M | (m) | $24.63M | $53.69M | (m) |
| 2022-03-31 | (m) | $48.89M | $114.35M | (m) | $26.90M | $42.87M | (m) |
| 2021-12-31 | (m) | $51.70M | $182.35M | (m) | $25.60M | $39.19M | (m) |
| 2021-09-30 | (m) | $41.41M | $230.51M | (m) | $19.30M | $34.30M | (m) |
| 2021-06-30 | (m) | $35.44M | $274.27M | (m) | $16.41M | $28.88M | (m) |
| 2021-03-31 | (m) | $34.82M | $251.77M | (m) | $12.11M | $24.55M | (m) |
| 2020-12-31 | (m) | $36.69M | $294.97M | (m) | $6.47M | $18.38M | (m) |
| 2020-09-30 | (m) | $33.04M | $311.33M | (m) | $7.08M | $11.81M | (m) |
| 2020-06-30 | (m) | (m) | $141.87M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $157.96M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $24.91M | $36.93M | (m) | $3.91M | $4.60M | (m) |
| 2019-09-30 | (m) | (m) | $39.22M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |